共有 50 笔近期内部人交易记录记录，涉及 Candel Therapeutics, Inc. (CADL), 包括 34 笔买入 和 15 笔卖出. 内部人买入总额为 $26.12M 内部人卖出总额为 $1.25M.
近期活跃的重要内部人包括 Papa Joseph C, Manning Paul B, Loggia Nicoletta. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — CADL
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-31 |
Papa Joseph C |
Director |
限制性股票授予 (RSU) |
2,795 |
$4.90 |
$13.7K |
2,795 |
| 2026-03-31 |
Manning Paul B |
Director |
限制性股票授予 (RSU) |
4,618 |
$4.90 |
$22.63K |
4,618 |
| 2026-03-31 |
Loggia Nicoletta |
Director |
限制性股票授予 (RSU) |
779 |
$4.90 |
$3.82K |
779 |
| 2026-02-23 |
Manning Paul B |
Director |
知情买入 |
550,458 |
$5.45 |
$3M |
2,763,527 |
| 2026-01-26 |
Nichols William Garrett |
Chief Medical Officer |
限制性股票授予 (RSU) |
136,500 |
$6.01 |
$820.37K |
136,500 |
| 2026-01-26 |
Tak Paul Peter |
Chief Executive Officer |
限制性股票授予 (RSU) |
629,000 |
$6.01 |
$3.78M |
629,000 |
| 2026-01-26 |
Barone Francesca |
Chief Scientific Officer |
限制性股票授予 (RSU) |
232,000 |
$6.01 |
$1.39M |
232,000 |
| 2026-01-26 |
Tyagarajan Seshu |
Chief Technology Officer |
限制性股票授予 (RSU) |
154,000 |
$6.01 |
$925.54K |
154,000 |
| 2026-01-26 |
Schoch Charles |
Chief Financial Officer |
限制性股票授予 (RSU) |
232,000 |
$6.01 |
$1.39M |
232,000 |
| 2025-07-28 |
Nichols William Garrett |
Chief Medical Officer |
期权行权（卖出） |
937 |
$1.29 |
$1.21K |
29,377 |
| 2025-06-30 |
Nichols William Garrett |
Chief Medical Officer |
期权行权（卖出） |
781 |
$1.29 |
$1.01K |
30,314 |
| 2025-06-25 |
Papa Joseph C |
Director |
限制性股票授予 (RSU) |
64,239 |
$4.67 |
$300K |
64,239 |
| 2025-06-25 |
Manning Paul B |
Director |
限制性股票授予 (RSU) |
1,070,663 |
$4.67 |
$5M |
2,213,069 |
| 2025-06-25 |
Nabel Gary J. |
Director |
限制性股票授予 (RSU) |
5,353 |
$4.67 |
$25K |
5,353 |
| 2025-06-25 |
Martell Christopher |
Director |
限制性股票授予 (RSU) |
111,349 |
$4.67 |
$520K |
111,349 |
| 2025-06-25 |
Tak Paul Peter |
Chief Executive Officer |
限制性股票授予 (RSU) |
42,826 |
$4.67 |
$200K |
268,566 |
| 2025-06-25 |
Barone Francesca |
Chief Scientific Officer |
限制性股票授予 (RSU) |
4,282 |
$4.67 |
$20K |
100,809 |
| 2025-06-25 |
Tyagarajan Seshu |
Chief Technology Officer |
限制性股票授予 (RSU) |
5,353 |
$4.67 |
$25K |
90,865 |
| 2025-06-25 |
Loggia Nicoletta |
Director |
限制性股票授予 (RSU) |
2,141 |
$4.67 |
$10K |
2,141 |
| 2025-06-25 |
Schoch Charles |
Chief Financial Officer |
限制性股票授予 (RSU) |
5,353 |
$4.67 |
$25K |
43,391 |
| 2025-06-20 |
Schoch Charles |
Chief Financial Officer |
限制性股票授予 (RSU) |
50,000 |
$4.75 |
$237.5K |
50,000 |
| 2025-06-17 |
Papa Joseph C |
Director |
限制性股票授予 (RSU) |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Manning Paul B |
Director |
限制性股票授予 (RSU) |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Benz Edward J. Jr |
Director |
限制性股票授予 (RSU) |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Gaeta Renee |
Director |
限制性股票授予 (RSU) |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Nguyen Diem |
Director |
限制性股票授予 (RSU) |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Nabel Gary J. |
Director |
限制性股票授予 (RSU) |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Martell Christopher |
Director |
限制性股票授予 (RSU) |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-17 |
Loggia Nicoletta |
Director |
限制性股票授予 (RSU) |
14,240 |
$4.94 |
$70.35K |
14,240 |
| 2025-06-04 |
Radhakrishnan Maha |
Officer |
未知 |
- |
- |
- |
- |
| 2025-06-04 |
Radhakrishnan Maha |
Director |
限制性股票授予 (RSU) |
28,480 |
$5.60 |
$159.49K |
28,480 |
| 2025-03-19 |
Tak Paul Peter |
Chief Executive Officer |
知情卖出 |
400 |
$9.00 |
$3.6K |
225,740 |
| 2025-03-18 |
Nichols William Garrett |
Chief Medical Officer |
期权行权（卖出） |
13,905 |
$1.29 |
$17.94K |
31,095 |
| 2025-03-18 |
Tak Paul Peter |
Chief Executive Officer |
知情卖出 |
25,772 |
$8.77 |
$226.02K |
226,140 |
| 2025-03-18 |
Barone Francesca |
Chief Scientific Officer |
期权行权（卖出） |
18,000 |
$1.55 |
$27.9K |
30,822 |
| 2025-03-17 |
Tyagarajan Seshu |
Chief Technology Officer |
期权行权（卖出） |
20,000 |
$1.29 |
$25.8K |
70,000 |
| 2025-03-17 |
Schoch Charles |
See Remarks |
知情卖出 |
5,000 |
$8.83 |
$44.17K |
38,038 |
| 2025-03-17 |
Tyagarajan Seshu |
Chief Technology Officer |
期权行权 |
20,000 |
$1.29 |
$25.8K |
116,790 |
| 2025-02-21 |
Aguilar-cordova Estuardo |
10 Percent Owner |
股份退回 |
10,582 |
$12.02 |
$127.2K |
120,861 |
| 2025-02-12 |
Nichols William Garrett |
Chief Medical Officer |
限制性股票授予 (RSU) |
107,250 |
$8.55 |
$916.99K |
107,250 |
| 2025-02-12 |
Tak Paul Peter |
Chief Executive Officer |
限制性股票授予 (RSU) |
525,000 |
$8.55 |
$4.49M |
525,000 |
| 2025-02-12 |
Barone Francesca |
Chief Scientific Officer |
限制性股票授予 (RSU) |
115,000 |
$8.55 |
$983.25K |
115,000 |
| 2025-02-12 |
Tyagarajan Seshu |
Chief Technology Officer |
限制性股票授予 (RSU) |
65,000 |
$8.55 |
$555.75K |
65,000 |
| 2025-02-12 |
Schoch Charles |
See Remarks |
限制性股票授予 (RSU) |
83,000 |
$8.55 |
$709.65K |
83,000 |
| 2025-02-10 |
Aguilar-cordova Estuardo |
10 Percent Owner |
股份退回 |
31,335 |
$8.61 |
$269.79K |
60,000 |
| 2025-01-15 |
Nichols William Garrett |
Chief Medical Officer |
知情卖出 |
10,428 |
$7.23 |
$75.34K |
79,320 |
| 2025-01-15 |
Tak Paul Peter |
Chief Executive Officer |
知情卖出 |
21,704 |
$7.23 |
$156.81K |
251,912 |
| 2025-01-15 |
Barone Francesca |
Chief Scientific Officer |
知情卖出 |
13,534 |
$7.23 |
$97.78K |
110,673 |
| 2025-01-15 |
Tyagarajan Seshu |
Chief Technology Officer |
知情卖出 |
14,322 |
$7.23 |
$103.48K |
96,790 |
| 2025-01-15 |
Schoch Charles |
See Remarks |
知情卖出 |
9,511 |
$7.23 |
$68.72K |
43,038 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
